BENESTERMYCIN DRY COW INTRAMAMMARY SUSPENSION
Country: Ireland
Language: English
Source: HPRA (Health Products Regulatory Authority)
Summary of Product characteristics
(SPC)
26-04-2024
Some documents for this product are not currently available, you can send a request to our customer service and we will notify you as soon as we are able to obtain them.
Send request.
Send request.
Active ingredient:
PENETHAMATE HYDRIODIDE BENETHAMINE PENICILLIN FRAMYCETIN SULFATE
Available from:
Boehringer Ingelheim Ltd
ATC code:
QJ51R
Pharmaceutical form:
intramammary Suspension
Therapeutic group:
Antibacterial
Therapeutic area:
Bovine
Authorization date:
2006-02-10
Summary of Product characteristics
IRISH MEDICINES BOARD ACT 1995
ANIMAL REMEDIES REGULATIONS, 2005
(S.I. NO. 734 OF 2005)
VPA: 10007/044/001
Case No: 7002927
The Irish Medicines Board in exercise of the powers conferred on it by Animal Remedies Regulations (S.I. No. 734 of 2005) hereby grants to:
BOEHRINGER INGELHEIM LTD
ELLESFIELD AVENUE, BRACKNELL, BERKSHIRE RG12 8YS, ENGLAND
an authorisation, subject to the provisions of the said Regulations and the general conditions of the attached authorisation, in respect of the
Veterinary Medicinal Product:
BENESTERMYCIN DRY COW INTRAMAMMARY SUSPENSION
The particulars of which are set out in Part 1 and Part 2 of the said Schedule. The authorisation is also subject to any special conditions as may
be specified in the said Schedule.
Signed on behalf of the Irish Medicines Board
________________
A person authorised in that behalf by the said Board.
(NOTE: This authorisation replaces any previous authorisation in respect of this product which is now null and void.)
IRISH MEDICINES BOARD
________________________________________________________________________________________________________________________
_Date Printed 01/03/2007_
_CRN 7002927_
_page number: 1_
PART II
SUMMARY OF PRODUCT CHARACTERISTICS
1 NAME OF THE VETERINARY MEDICINAL PRODUCT
BENESTERMYCIN Dry Cow Intramammary Suspension
2 QUALITATIVE AND QUANTITATIVE COMPOSITION
3 PHARMACEUTICAL FORM
Intramammary suspension.
4 CLINICAL PARTICULARS
4.1 TARGET SPECIES
Cattle
4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES
For routine treatment of subclinical infection present at drying off and to assist in the prevention of new infections
during the dry period.
In vitro efficacy has been demonstrated against:
Staphylococcus spp
Streptococcus spp
Actinomyces (Corynebacterium)
Escherichia coli
Klebsiella spp
Pseudomonas spp
4.3 CONTRAINDICATIONS
Do not
Read the complete document
